These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 17640155)

  • 1. Safety and tolerability of antidepressants: weighing the impact on treatment decisions.
    Schatzberg AF
    J Clin Psychiatry; 2007; 68 Suppl 8():26-34. PubMed ID: 17640155
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The efficacy, tolerability, and safety of contemporary antidepressants.
    Papakostas GI
    J Clin Psychiatry; 2010; 71 Suppl E1():e03. PubMed ID: 20371030
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Duloxetine in the treatment of major psychiatric and neuropathic disorders.
    Müller N; Schennach R; Riedel M; Möller HJ
    Expert Rev Neurother; 2008 Apr; 8(4):527-36. PubMed ID: 18416656
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Duloxetine: review of its pharmacology, and therapeutic use in depression and other psychiatric disorders.
    Gupta S; Nihalani N; Masand P
    Ann Clin Psychiatry; 2007; 19(2):125-32. PubMed ID: 17612852
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Strategies for switching antidepressants to achieve maximum efficacy adolescents.
    Jefferson JW
    J Clin Psychiatry; 2008; 69 Suppl E1():14-8. PubMed ID: 18494539
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Six-month compliance with antidepressant medication in the treatment of major depressive disorder.
    Demyttenaere K; Adelin A; Patrick M; Walthère D; Katrien de B; Michèle S
    Int Clin Psychopharmacol; 2008 Jan; 23(1):36-42. PubMed ID: 18090506
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [New antidepressive drugs].
    Woggon B
    Praxis (Bern 1994); 2000 Mar; 89(13):524-8. PubMed ID: 10776054
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [New antidepressant drugs. What side effects and interactions are to be expected?].
    Degner D; Grohmann R; Bleich S; Rüther E
    MMW Fortschr Med; 2000 Dec; 142(49-50):35-8, 40. PubMed ID: 11190936
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Escitalopram for the treatment of major depression and anxiety disorders.
    Höschl C; Svestka J
    Expert Rev Neurother; 2008 Apr; 8(4):537-52. PubMed ID: 18416657
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Emerging drugs for major depressive disorder.
    Kennedy SH; Rizvi SJ
    Expert Opin Emerg Drugs; 2009 Sep; 14(3):439-53. PubMed ID: 19637989
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Consensus recommendations for improving adherence, self-management, and outcomes in patients with depression.
    Trivedi MH; Lin EH; Katon WJ
    CNS Spectr; 2007 Aug; 12(8 Suppl 13):1-27. PubMed ID: 17986951
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Why antidepressants are not antidepressants: STEP-BD, STAR*D, and the return of neurotic depression.
    Ghaemi SN
    Bipolar Disord; 2008 Dec; 10(8):957-68. PubMed ID: 19594510
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Guidelines and reality in practical use of and compliance to antidepressants in the treatment of depression: incidence survey in Lorraine and Champagne-Ardenne (France)].
    Hérique A; Kahn JP
    Encephale; 2009 Feb; 35(1):73-9. PubMed ID: 19250997
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Evolution of benefit-risk ratio of antidepressants].
    Corruble E; Guelfi JD
    Therapie; 1995; 50(6):515-21. PubMed ID: 8745950
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Rationalizing the prescription of antidepressants].
    Boulenger JP; Attal J
    Rev Prat; 2008 Feb; 58(4):395-402. PubMed ID: 18506979
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Desvenlafaxine succinate for major depressive disorder: a critical review of the evidence.
    Kamath J; Handratta V
    Expert Rev Neurother; 2008 Dec; 8(12):1787-97. PubMed ID: 19086875
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Initial treatment approaches for patients with major depressive disorder.
    Papakostas GI
    J Clin Psychiatry; 2009 Jun; 70(6):e18. PubMed ID: 19573474
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Augmentation strategies to increase antidepressant tolerability.
    Zajecka JM
    J Clin Psychiatry; 2007; 68 Suppl 10():23-7. PubMed ID: 17900206
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Selective and safe. Review of new antidepressive drugs].
    Neumeister A; Stastny J
    MMW Fortschr Med; 2000 Dec; 142(49-50):28, 31-2. PubMed ID: 11190935
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Augmentation of antidepressants with perospirone for treatment-resistant major depressive disorder.
    Sato Y; Yasui-Furukori N; Nakagami T; Saito M; Kaneko S
    Prog Neuropsychopharmacol Biol Psychiatry; 2009 Apr; 33(3):416-8. PubMed ID: 19166896
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.